Joshua Gulvin

11PUBLICATIONS
35CO-AUTHORS
Preventative health careDisease surveillanceBanking, finance and securities lawChemotherapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 17, 2025
High Grade Anal Dysplasia in People Living with HIV: A Review of the Anal Cancer/HSIL Outcomes Research (ANCHOR) Trial. Implications for Screening and Treatment Strategies to Minimize Anal Cancer in a Very High-risk Population.

David M Aboulafia

|Mar 06, 2025
Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01).

Thomas M Atkinson, Madhu Mazumdar, Grace Van Hyfte

|Feb 27, 2024
Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide.

Charles L Bennett, Jason B Gibbons, Antonio Trujillo

|Jul 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087).

Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao

|Jun 15, 2022
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.

Joel M Palefsky, Jeannette Y Lee, Naomi Jay

|Mar 05, 2022
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.

Erin G Reid, Kelly Shimabukuro, Page Moore

Pageof 2

Frequent Collaborators

2 joint publications

Joseph Sparano

2 joint publications

William Wachsman

2 joint publications

Elizabeth Yu Chiao

2 joint publications

Jeannette Y Lee